{"id":16717,"date":"2025-03-26T14:48:08","date_gmt":"2025-03-26T14:48:08","guid":{"rendered":"https:\/\/www.cryoport.com\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/"},"modified":"2026-02-13T10:23:31","modified_gmt":"2026-02-13T15:23:31","slug":"mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/","title":{"rendered":"Mark Sawicki, PDG de Pharma Focus Asia, parle de l’avenir de la th\u00e9rapie cellulaire et g\u00e9nique"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

L’industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d’introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l’avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d’expert sur les principaux moteurs de la croissance, l’importance de la normalisation et le r\u00f4le critique d’une cha\u00eene d’approvisionnement \u00e9volutive dans l’avancement de l’industrie. <\/p>\n","protected":false},"author":38,"featured_media":16664,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[226],"tags":[],"class_list":["post-16717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles-fr"],"acf":[],"yoast_head":"\nMark Sawicki, PDG de Pharma Focus Asia, parle de l'avenir de la th\u00e9rapie cellulaire et g\u00e9nique - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"L'industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d'introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l'avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d'expert sur les principaux moteurs de la croissance, l'importance de la normalisation et le r\u00f4le critique d'une cha\u00eene d'approvisionnement \u00e9volutive dans l'avancement de l'industrie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mark Sawicki, PDG de Pharma Focus Asia, parle de l'avenir de la th\u00e9rapie cellulaire et g\u00e9nique - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"L'industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d'introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l'avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d'expert sur les principaux moteurs de la croissance, l'importance de la normalisation et le r\u00f4le critique d'une cha\u00eene d'approvisionnement \u00e9volutive dans l'avancement de l'industrie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-26T14:48:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T15:23:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature-1024x536.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"Mark Sawicki, PDG de Pharma Focus Asia, parle de l’avenir de la th\u00e9rapie cellulaire et g\u00e9nique\",\"datePublished\":\"2025-03-26T14:48:08+00:00\",\"dateModified\":\"2026-02-13T15:23:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\"},\"wordCount\":19,\"publisher\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png\",\"articleSection\":[\"Articles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\",\"url\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\",\"name\":\"Mark Sawicki, PDG de Pharma Focus Asia, parle de l'avenir de la th\u00e9rapie cellulaire et g\u00e9nique - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png\",\"datePublished\":\"2025-03-26T14:48:08+00:00\",\"dateModified\":\"2026-02-13T15:23:31+00:00\",\"description\":\"L'industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d'introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l'avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d'expert sur les principaux moteurs de la croissance, l'importance de la normalisation et le r\u00f4le critique d'une cha\u00eene d'approvisionnement \u00e9volutive dans l'avancement de l'industrie.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage\",\"url\":\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png\",\"contentUrl\":\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png\",\"width\":4800,\"height\":2513},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cryoport.com\/fr\/homepage\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mark Sawicki, PDG de Pharma Focus Asia, parle de l’avenir de la th\u00e9rapie cellulaire et g\u00e9nique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/#website\",\"url\":\"https:\/\/www.cryoport.com\/fr\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\/\/www.cryoport.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png\",\"contentUrl\":\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/cryoport\",\"https:\/\/www.linkedin.com\/company\/856887\",\"https:\/\/www.youtube.com\/user\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mark Sawicki, PDG de Pharma Focus Asia, parle de l'avenir de la th\u00e9rapie cellulaire et g\u00e9nique - Cryoport Systems","description":"L'industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d'introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l'avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d'expert sur les principaux moteurs de la croissance, l'importance de la normalisation et le r\u00f4le critique d'une cha\u00eene d'approvisionnement \u00e9volutive dans l'avancement de l'industrie.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/","og_locale":"fr_FR","og_type":"article","og_title":"Mark Sawicki, PDG de Pharma Focus Asia, parle de l'avenir de la th\u00e9rapie cellulaire et g\u00e9nique - Cryoport Systems","og_description":"L'industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d'introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l'avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d'expert sur les principaux moteurs de la croissance, l'importance de la normalisation et le r\u00f4le critique d'une cha\u00eene d'approvisionnement \u00e9volutive dans l'avancement de l'industrie.","og_url":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/","og_site_name":"Cryoport Systems","article_published_time":"2025-03-26T14:48:08+00:00","article_modified_time":"2026-02-13T15:23:31+00:00","og_image":[{"width":1024,"height":536,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature-1024x536.png","type":"image\/png"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"\u00c9crit par":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"Mark Sawicki, PDG de Pharma Focus Asia, parle de l’avenir de la th\u00e9rapie cellulaire et g\u00e9nique","datePublished":"2025-03-26T14:48:08+00:00","dateModified":"2026-02-13T15:23:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/"},"wordCount":19,"publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png","articleSection":["Articles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/","url":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/","name":"Mark Sawicki, PDG de Pharma Focus Asia, parle de l'avenir de la th\u00e9rapie cellulaire et g\u00e9nique - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png","datePublished":"2025-03-26T14:48:08+00:00","dateModified":"2026-02-13T15:23:31+00:00","description":"L'industrie de la th\u00e9rapie cellulaire et g\u00e9nique (CGT) continue d'introduire de nouvelles perc\u00e9es qui fa\u00e7onnent l'avenir de la m\u00e9decine. Dans le dernier num\u00e9ro de Pharma Focus Asia, le PDG de Cryoport Systems, Mark Sawicki, Ph.D., partage son point de vue d'expert sur les principaux moteurs de la croissance, l'importance de la normalisation et le r\u00f4le critique d'une cha\u00eene d'approvisionnement \u00e9volutive dans l'avancement de l'industrie.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/03\/Blog_Mark-Sawicki-Feature.png","width":4800,"height":2513},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/fr\/mark-sawicki-pdg-de-pharma-focus-asia-parle-de-lavenir-de-la-therapie-cellulaire-et-genique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/fr\/homepage\/"},{"@type":"ListItem","position":2,"name":"Mark Sawicki, PDG de Pharma Focus Asia, parle de l’avenir de la th\u00e9rapie cellulaire et g\u00e9nique"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/fr\/#website","url":"https:\/\/www.cryoport.com\/fr\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/fr\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/16717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/comments?post=16717"}],"version-history":[{"count":1,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/16717\/revisions"}],"predecessor-version":[{"id":25850,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/16717\/revisions\/25850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media\/16664"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media?parent=16717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/categories?post=16717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/tags?post=16717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}